China Shun Ke Long Holdings Ltd
HKEX:974
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
China Shun Ke Long Holdings Ltd
HKEX:974
|
CN |
|
W
|
WK Kellogg Co
NYSE:KLG
|
US |
|
K
|
Keen Ocean International Holding Ltd
HKEX:8070
|
HK |
|
Sichuan Golden Summit Group Joint Stock Co Ltd
SSE:600678
|
CN |
|
Zurich Insurance Group AG
LSE:0QP2
|
CH |
|
A
|
Aarti Pharmalabs Ltd
NSE:AARTIPHARM
|
IN |
|
S
|
Shanghai Henlius Biotech Inc
HKEX:2696
|
CN |
|
N
|
Nahar Capital and Financial Services Ltd
NSE:NAHARCAP
|
IN |
|
N
|
Nahar Poly Films Ltd
NSE:NAHARPOLY
|
IN |
|
Airgain Inc
NASDAQ:AIRG
|
US |
|
Kriti Nutrients Ltd
NSE:KRITINUT
|
IN |
|
SIASUN Robot & Automation Co Ltd
SZSE:300024
|
CN |
Balance Sheet
Balance Sheet Decomposition
China Shun Ke Long Holdings Ltd
China Shun Ke Long Holdings Ltd
Balance Sheet
China Shun Ke Long Holdings Ltd
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
20
|
38
|
26
|
201
|
152
|
165
|
122
|
123
|
104
|
103
|
49
|
49
|
21
|
40
|
|
| Cash Equivalents |
20
|
38
|
26
|
201
|
152
|
165
|
122
|
123
|
104
|
103
|
49
|
49
|
21
|
40
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
60
|
45
|
44
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
222
|
60
|
123
|
98
|
124
|
107
|
97
|
98
|
100
|
82
|
74
|
84
|
85
|
27
|
|
| Accounts Receivables |
12
|
39
|
76
|
36
|
54
|
39
|
24
|
24
|
35
|
25
|
29
|
37
|
35
|
27
|
|
| Other Receivables |
210
|
22
|
47
|
61
|
70
|
68
|
72
|
75
|
64
|
58
|
46
|
47
|
50
|
0
|
|
| Inventory |
119
|
114
|
129
|
154
|
149
|
151
|
163
|
166
|
166
|
125
|
124
|
94
|
97
|
47
|
|
| Other Current Assets |
2
|
5
|
12
|
6
|
4
|
5
|
3
|
2
|
1
|
0
|
10
|
8
|
8
|
57
|
|
| Total Current Assets |
363
|
216
|
290
|
458
|
429
|
428
|
445
|
434
|
414
|
311
|
257
|
234
|
211
|
172
|
|
| PP&E Net |
38
|
40
|
50
|
77
|
65
|
52
|
50
|
142
|
164
|
147
|
114
|
115
|
78
|
50
|
|
| PP&E Gross |
38
|
40
|
50
|
77
|
65
|
52
|
50
|
142
|
164
|
147
|
114
|
115
|
78
|
0
|
|
| Accumulated Depreciation |
15
|
24
|
32
|
41
|
48
|
52
|
54
|
56
|
68
|
76
|
81
|
86
|
98
|
0
|
|
| Goodwill |
0
|
0
|
3
|
3
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
5
|
5
|
4
|
4
|
4
|
4
|
4
|
10
|
10
|
9
|
9
|
9
|
8
|
8
|
|
| Other Long-Term Assets |
38
|
39
|
40
|
40
|
39
|
38
|
40
|
11
|
12
|
14
|
10
|
7
|
7
|
9
|
|
| Other Assets |
0
|
0
|
3
|
3
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
445
N/A
|
301
-32%
|
387
+29%
|
582
+50%
|
539
-7%
|
526
-3%
|
543
+3%
|
597
+10%
|
600
+1%
|
482
-20%
|
390
-19%
|
366
-6%
|
305
-17%
|
238
-22%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
67
|
130
|
141
|
143
|
134
|
110
|
112
|
116
|
103
|
80
|
95
|
78
|
67
|
45
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
15
|
13
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
60
|
8
|
28
|
62
|
62
|
|
| Current Portion of Long-Term Debt |
200
|
32
|
57
|
52
|
104
|
92
|
108
|
18
|
140
|
38
|
23
|
24
|
24
|
13
|
|
| Other Current Liabilities |
134
|
55
|
118
|
56
|
46
|
59
|
44
|
40
|
42
|
47
|
31
|
24
|
25
|
39
|
|
| Total Current Liabilities |
400
|
216
|
316
|
251
|
284
|
261
|
265
|
174
|
284
|
225
|
173
|
170
|
191
|
160
|
|
| Long-Term Debt |
0
|
0
|
0
|
80
|
0
|
0
|
0
|
165
|
77
|
56
|
40
|
45
|
32
|
12
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Minority Interest |
0
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Liabilities |
400
N/A
|
217
-46%
|
317
+46%
|
332
+5%
|
285
-14%
|
263
-8%
|
266
+1%
|
341
+28%
|
362
+6%
|
282
-22%
|
214
-24%
|
216
+1%
|
223
+3%
|
175
-22%
|
|
| Equity | |||||||||||||||
| Common Stock |
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Retained Earnings |
45
|
84
|
41
|
51
|
75
|
87
|
98
|
77
|
61
|
23
|
2
|
29
|
97
|
62
|
|
| Additional Paid In Capital |
0
|
0
|
30
|
195
|
170
|
170
|
170
|
170
|
170
|
170
|
170
|
170
|
170
|
0
|
|
| Other Equity |
0
|
0
|
0
|
2
|
7
|
3
|
6
|
7
|
5
|
5
|
5
|
6
|
6
|
0
|
|
| Total Equity |
45
N/A
|
84
+87%
|
70
-17%
|
250
+256%
|
254
+2%
|
263
+3%
|
276
+5%
|
256
-7%
|
238
-7%
|
200
-16%
|
176
-12%
|
149
-15%
|
81
-45%
|
64
-21%
|
|
| Total Liabilities & Equity |
445
N/A
|
301
-32%
|
387
+29%
|
582
+50%
|
539
-7%
|
526
-3%
|
543
+3%
|
597
+10%
|
600
+1%
|
482
-20%
|
390
-19%
|
366
-6%
|
305
-17%
|
238
-22%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
287
|
287
|
286
|
290
|
290
|
290
|
290
|
290
|
290
|
290
|
290
|
290
|
290
|
290
|
|